Nurexone Biologic Inc (NRXBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 983 | 1,228 | 588 | 700 | 2,523 |
| Marketable Securities | 41 | 41 | 41 | 41 | 41 |
| Receivables | 122 | 84 | 135 | 293 | 259 |
| TOTAL | $1,146 | $1,953 | $1,364 | $1,634 | $2,823 |
| Non-Current Assets | |||||
| PPE Net | 764 | 778 | 740 | 759 | 736 |
| Other Non-Current Assets | 736 | 133 | 36 | 48 | 55 |
| TOTAL | $1,500 | $911 | $776 | $807 | $791 |
| Total Assets | $2,646 | $2,864 | $2,140 | $2,441 | $3,614 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 496 | 678 | 366 | 232 | 263 |
| Accrued Expenses | 366 | 329 | 187 | 166 | 172 |
| TOTAL | $862 | $1,007 | $553 | $398 | $435 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 327 | 325 | 271 | 282 | 251 |
| TOTAL | $327 | $325 | $271 | $282 | $251 |
| Total Liabilities | $1,189 | $1,332 | $824 | $680 | $686 |
| Shareholders' Equity | |||||
| Retained earnings | -24,089 | -22,624 | -20,778 | -19,100 | -17,554 |
| Other shareholders' equity | 1,723 | 1,403 | 1,681 | 1,395 | 2,699 |
| TOTAL | $1,457 | $1,532 | $1,316 | $1,761 | $2,928 |
| Total Liabilities And Equity | $2,646 | $2,864 | $2,140 | $2,441 | $3,614 |